Fibroblast growth factor -2 (FGF-2) was found to activate SRPK1 amongst other splicing proteins to promote VEGFR1 AS in NSCLC cells, contributing to angiogenesis and progression of NSCLC [76]. This evidence concerns the gene SRPK1 and non-small cell lung carcinoma.